Nivolumab with ipilimumab for untreated advanced renal cell carcinoma

Supporting evidence

• Evaluation report

• Committee papers (TA780) (PDF 2.71 MB)

  Published:

  24 March 2022

• Appraisal consultation committee papers (TA581) (PDF 7.05 MB)

  Published:

  15 May 2019

• Final appraisal determination committee papers (TA581) (PDF 2.8 MB)

  Published:

  15 May 2019